Chronic Complications of Peptide Receptor Radionuclide Therapy (PRRT) - A Single Center Experience.

被引:0
|
作者
Fraenkel, M. [1 ]
Barak, D. [1 ]
Mueller-Brand, J. [2 ]
Krausz, Y. [1 ]
Glaser, B. [1 ]
Salmon, A. [1 ]
Gross, D. J. [1 ]
机构
[1] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
[2] Univ Basel Hosp, CH-4031 Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [1] Chronic Complications of Peptide Receptor Radionuclide Therapy (PRRT) - A Single Center Experience
    Fraenkel, M.
    Barak, D.
    Mueller-Brand, J.
    Krausz, Y.
    Glaser, B.
    Salmon, A.
    Gross, D. J.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 30 - 30
  • [2] Renal and Hepatotoxicity of Peptide Receptor Radionuclide Therapy (PRRT) - A Single Institution Experience
    Duan, H.
    Ferri, V.
    Kunz, P.
    Davidzon, G.
    Nguyen, J.
    Moradi, F.
    Franc, B.
    Iagaru, A.
    Aparici, C. Mari
    PANCREAS, 2021, 50 (03) : 456 - 457
  • [3] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [4] Single Institution Experience with Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ninatti, G.
    Girod, B.
    Ferri, V
    Guja, K.
    Song, H.
    Kunz, P.
    Fisher, G.
    Lagaru, A.
    Mari, Aparici C.
    NEUROENDOCRINOLOGY, 2020, 110 : 253 - 253
  • [5] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Kunz, Pamela L.
    Fisher, George A.
    Moradi, Farshad
    Davidzon, Guido Alejandro
    Franc, Benjamin Lewis
    Iagaru, Andrei
    Mari, Carina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [6] Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P.
    Davidzon, G.
    Nguyen, J.
    Moradi, F.
    Franc, B.
    Iagaru, A.
    Aparici, C. Mari
    PANCREAS, 2021, 50 (03) : 456 - 456
  • [7] A single institution experience with peptide receptor radionuclide therapy (PRRT) in advanced pheochromocytoma and paraganglioma
    Duan, H.
    Ferri, V
    Fisher, G.
    Shaheen, S.
    Davidzon, G.
    Moradi, F.
    Nguyen, J.
    Franc, B.
    Iagaru, A.
    Mari, Aparici C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 180 - 180
  • [8] Non-responders to Peptide Receptor Radionuclide Therapy (PRRT) - A single center retrospective analysis
    Laffi, A.
    Rodari, M.
    Lania, A. G. A.
    Zerbi, A.
    Elisabetta, L.
    Uccella, S.
    Spaggiari, P.
    Carrara, S.
    Pedicini, V
    Procopio, F.
    Capretti, G. L.
    Bertuzzi, A. F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 194 - 194
  • [9] Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET): A single institution experience in the USA
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S468 - S469
  • [10] Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Institution Experience
    Duan, Heying
    Ferri, Valentina
    Fisher, George A.
    Shaheen, Shagufta
    Davidzon, Guido A.
    Moradi, Farshad
    Nguyen, Judy
    Franc, Ben L.
    Iagaru, Andrei
    Aparici, Carina Mari
    PANCREAS, 2022, 51 (03) : E42 - E43